The examination of ARB drugs by the FDA will be extended to include other generics with similar manufacturing processes to identify impurities.
List view / Grid view
Filter the results
The Food and Drug Administration has released a list of 40 drugs used to treat hypertension and heart failure that don’t contain any known carcinogens...
The MHRA have announced another sartan-containing drug product over fears that it is contaminated with the carcinogen N‑nitrosodiethylamine...
“Our finding of reduced aortic dilatation with irbesartan, over and above standard medical therapy, suggests an important clinical effect that may prevent complications and ultimately delay or obviate the need for surgical intervention in patients with Marfan syndrome,” said Dr Mullen.